Zachary R. Healy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zachary R. Healy has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Alicia Cooper-Volkheimer
2 shared publicationsDavid Murdoch
2 shared publications- Albena T. Dinkova Kostova
Jacqui Wood Cancer Centre, Division of Cancer Research, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK
1 shared publication - Anant Madabhushi
Department of Biomedical Engineering, Emory University, Atlanta, GA
1 shared publication Andrea L. Benedict
Lewis B. and Dorothy Cullman Cancer Chemoprotection Center, Department of Pharmacology and Molecular Sciences
1 shared publication- Bastiaan Driehuys
Medical Physics Graduate Program Duke University Durham USA
1 shared publication
Latest Publications
- Open Access
Radiomics of the Airway (RadAr): Multi-Scale Airway Phenotyping for Disease Characterization on Routine CT Imaging
Background: Airway remodeling is a convergent feature across respiratory diseases, yet current quantitative CT tools quantify a small number of prespecified structural abnormalities of the airway tree. Radiomics of the Airway (RadAr) derives interpretable, multi-scale airway measurements from chest CT to characterize airway deformation and discover quantitative imaging biomarkers from routine chest CT. Methods: RadAr extracts over 400 multi-scale, interpretable airway measurements across lobes or generations capturing luminal dimensions, tapering, architectural distortion, and global morphology. It was evaluated in N=1331 patients across four settings: 63-week mortality prediction in fibrotic interstitial lung disease (fILD), COVID-19 severity prediction, structure-function association in progressive pulmonary fibrosis (PPF) and structure-inflammation markers in pediatric cystic fibrosis (CF). Unsupervised clustering was used to identify airway phenotypes across the fILD and COVID-19 cohorts. Results: In fILD, lower-lobe architectural distortion was associated with mortality (balanced accuracy 0·654). In COVID-19, severe disease was independently associated with luminal dilation (AUC 0·719, odds ratio 2·32, p=0·017). In PPF, airway phenotypes correlated with forced vital capacity (ρ=0·83), mid-expiratory flow (ρ=0·87), and ¹²⁹Xe MRI alveolar gas exchange impairment (ρ=0·70). In pediatric CF, reduced tapering and increased cylindricity were associated with prior exacerbations and bronchoalveolar lavage neutrophilia (ρ=-0·64 to -0·78). Five phenotypes were identified from extensive, tapered airway trees to sparse, dilated, thick-walled, tortuous trees, with increasing COVID-19 severity and fILD mortality across this spectrum. Conclusion: RadAr identified interpretable, disease-specific airway phenotypes associated with function and outcomes across restrictive, obstructive, and mixed lung diseases in adult and pediatric settings. These findings establish a framework for discovery and development of quantitative airway biomarkers for patient stratification, disease monitoring, or imaging endpoint development in pulmonary trials.
Open AccessRadiomics of the Airway (RadAr): Multi-Scale Airway Phenotyping for Disease Characterization on Routine CT Imaging
Background: Airway remodeling is a convergent feature across respiratory diseases, yet current quantitative CT tools quantify a small number of prespecified structural abnormalities of the airway tree. Radiomics of the Airway (RadAr) derives interpretable, multi-scale airway measurements from chest CT to characterize airway deformation and discover quantitative imaging biomarkers from routine chest CT. Methods: RadAr extracts over 400 multi-scale, interpretable airway measurements across lobes or generations capturing luminal dimensions, tapering, architectural distortion, and global morphology. It was evaluated in N=1331 patients across four settings: 63-week mortality prediction in fibrotic interstitial lung disease (fILD), COVID-19 severity prediction, structure-function association in progressive pulmonary fibrosis (PPF) and structure-inflammation markers in pediatric cystic fibrosis (CF). Unsupervised clustering was used to identify airway phenotypes across the fILD and COVID-19 cohorts. Results: In fILD, lower-lobe architectural distortion was associated with mortality (balanced accuracy 0·654). In COVID-19, severe disease was independently associated with luminal dilation (AUC 0·719, odds ratio 2·32, p=0·017). In PPF, airway phenotypes correlated with forced vital capacity (ρ=0·83), mid-expiratory flow (ρ=0·87), and ¹²⁹Xe MRI alveolar gas exchange impairment (ρ=0·70). In pediatric CF, reduced tapering and increased cylindricity were associated with prior exacerbations and bronchoalveolar lavage neutrophilia (ρ=-0·64 to -0·78). Five phenotypes were identified from extensive, tapered airway trees to sparse, dilated, thick-walled, tortuous trees, with increasing COVID-19 severity and fILD mortality across this spectrum. Conclusion: RadAr identified interpretable, disease-specific airway phenotypes associated with function and outcomes across restrictive, obstructive, and mixed lung diseases in adult and pediatric settings. These findings establish a framework for discovery and development of quantitative airway biomarkers for patient stratification, disease monitoring, or imaging endpoint development in pulmonary trials.
- Open Access
- 17 August 2023
- Published by Springer Nature
U54 SCENT T/NK Immunosenescence Profiling Flow Cytometry Panel v1
This protocol describes the T/NK Immunosenescence Profiling Flow Cytometry Panel
- 17 August 2023
- Published by Springer Nature
Open AccessU54 SCENT T/NK Immunosenescence Profiling Flow Cytometry Panel v1
This protocol describes the T/NK Immunosenescence Profiling Flow Cytometry Panel
- Open Access
- 17 August 2023
- Published by Springer Nature
U54 SCENT Intracellular Staining (ICS) Senescence Flow Cytometry Panel v1
This protocol describes the Intracellular Staining (ICS) Senescence Flow Cytometry Panel
- 17 August 2023
- Published by Springer Nature
Open AccessU54 SCENT Intracellular Staining (ICS) Senescence Flow Cytometry Panel v1
This protocol describes the Intracellular Staining (ICS) Senescence Flow Cytometry Panel
- Open Access
- 30 October 2007
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (44) , 17500-17505
Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation
UV radiation (UVR) is a complete carcinogen that elicits a constellation of pathological events, including direct DNA damage, generation of reactive oxidants that peroxidize lipids and damage other cellular components, initiation of inflammation, and suppression of the immune response. Recent dramatic increases in the incidence of nonmelanoma skin cancers are largely attributable to higher exposure of an aging population to UVR. Therefore, the development of cellular strategies for intrinsic protection of the skin against the deleterious effects of UVR is imperative. Here we show that erythema resulting from UVR is a comprehensive and noninvasive biomarker for assessing UVR damage and can be precisely and easily quantified in human skin. Topical application of sulforaphane-rich extracts of 3-day-old broccoli sprouts up-regulated phase 2 enzymes in the mouse and human skin, protected against UVR-induced inflammation and edema in mice, and reduced susceptibility to erythema arising from narrow-band 311-nm UVR in humans. In six human subjects (three males and three females, 28–53 years of age), the mean reduction in erythema across six doses of UVR (300–800 mJ/cm 2 in 100 mJ/cm 2 increments) was 37.7% (range 8.37–78.1%; P = 0.025). This protection against a carcinogen in humans is catalytic and long lasting.
- 30 October 2007
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (44) , 17500-17505
Open AccessSulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation
UV radiation (UVR) is a complete carcinogen that elicits a constellation of pathological events, including direct DNA damage, generation of reactive oxidants that peroxidize lipids and damage other cellular components, initiation of inflammation, and suppression of the immune response. Recent dramatic increases in the incidence of nonmelanoma skin cancers are largely attributable to higher exposure of an aging population to UVR. Therefore, the development of cellular strategies for intrinsic protection of the skin against the deleterious effects of UVR is imperative. Here we show that erythema resulting from UVR is a comprehensive and noninvasive biomarker for assessing UVR damage and can be precisely and easily quantified in human skin. Topical application of sulforaphane-rich extracts of 3-day-old broccoli sprouts up-regulated phase 2 enzymes in the mouse and human skin, protected against UVR-induced inflammation and edema in mice, and reduced susceptibility to erythema arising from narrow-band 311-nm UVR in humans. In six human subjects (three males and three females, 28–53 years of age), the mean reduction in erythema across six doses of UVR (300–800 mJ/cm 2 in 100 mJ/cm 2 increments) was 37.7% (range 8.37–78.1%; P = 0.025). This protection against a carcinogen in humans is catalytic and long lasting.